Genexine has ranked among the top searched stocks for 5 days in the past month.

As of 10:30 AM on the 25th, Genexine is trading at 97,600 KRW, down 1.11% from the previous day. This represents a 30.83% increase compared to June 3. Genexine is known as a specialized company in biopharmaceutical development.

Today, foreigners are tentatively recorded as net buyers of 6,000 shares. Over the past 5 days, individual investors have net purchased 701,061 shares, while foreigners and institutions have net sold 60,109 shares and 75,721 shares, respectively.

On June 19, Genexine became a market issue with the news of the "first domestic" COVID-19 vaccine administered to humans, causing a "surge."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing